Wink Biotherapeutics
PrivateLast Round
Pre Seed
May 19, 2025
Total Funding Raised
$105,000
Company Overview
Wink Biotherapeutics is a drug discovery company that develops a proprietary RNA aptamer technology with precise targeting of disease mechanisms for patients with autoimmune and oncologic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wink Biotherapeutics Comparables
Compare Wink Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DiogenX | 80% | |
| TIXiMED | 79% | |
| Kriya Therapeutics | 71% |
Wink Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 19, 2025 | ||||
| Grant | Dec 9, 2024 | ||||
| Accelerator | Jul 6, 2023 |
Wink Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dreamward Ventures | Pre Seed |
| Venture Black | Pre Seed |
| Venture Black | Pre Seed |
| BioFlorida, Inc. | Grant |
| StartUp Health | Pre Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 446% MoM, reaching 1.4K.
- May 19, 2025
$75K raised from StartUp Health and Dreamward Ventures.
Wink Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Wink Biotherapeutics's valuation, stock price, and market status.
Is Wink Biotherapeutics a public or private company?
Wink Biotherapeutics is a private company.
What is the current stock price of Wink Biotherapeutics?
Wink Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Wink Biotherapeutics worth (valuation)?
Valuation information for Wink Biotherapeutics is not publicly available.
Can I buy Wink Biotherapeutics stock?
Wink Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Wink Biotherapeutics's last funding round?
Wink Biotherapeutics's most recent funding round was Pre Seed on May 19, 2025.
Who are the main investors in Wink Biotherapeutics?
Key investors in Wink Biotherapeutics include Dreamward Ventures, Venture Black, Venture Black, BioFlorida, Inc., StartUp Health.
Will Wink Biotherapeutics IPO soon?
No public IPO plans have been announced for Wink Biotherapeutics.
How can I track Wink Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Wink Biotherapeutics's secondary market activity and sign up for updates.